Filed with ASX · · 2 pages · English
He will succeed the current CFO, Simon Martin, who will continue to support the company for an additional six months. The CEO expressed confidence that Jan's experience will be crucial for the company's international expansion.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ASX ANNOUNCEMENT 20 October 2026 Vitrafy appoints Jan Gielen as Chief Financial Officer Vitrafy Life Sciences Limited (ASX: VFY), (Vitrafy or the Company), a medical device Company that has designed and developed an innovative solution for the advancement of cryopreservation, today announces the...
Vitrafy Life Sciences Ltd. on 6ix
Follow Vitrafy Life Sciences into a list and get an email when it puts out news.
Follow Vitrafy Life Sciences